Nowak AK - Search Results

1

Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice.

Zemek RM, Chin WL, Fear VS, Wylie B, Casey TH, Forbes C, Tilsed CM, Boon L, Guo BB, Bosco A, Forrest ARR, Millward MJ, Nowak AK, Lake RA, Lassmann T, Lesterhuis WJ. Zemek RM, et al. Among authors: nowak ak. Nat Commun. 2022 Aug 19;13(1):4895. doi: 10.1038/s41467-022-32567-8. Nat Commun. 2022. PMID: 35986006 Free PMC article.

2

New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents.

Nowak AK, Lake RA, Kindler HL, Robinson BW. Nowak AK, et al. Semin Oncol. 2002 Feb;29(1):82-96. doi: 10.1053/sonc.2002.30234. Semin Oncol. 2002. PMID: 11836673 Review.

3

Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy.

Nowak AK, Robinson BW, Lake RA. Nowak AK, et al. Cancer Res. 2002 Apr 15;62(8):2353-8. Cancer Res. 2002. PMID: 11956096

4

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells.

Nowak AK, Lake RA, Marzo AL, Scott B, Heath WR, Collins EJ, Frelinger JA, Robinson BW. Nowak AK, et al. J Immunol. 2003 May 15;170(10):4905-13. doi: 10.4049/jimmunol.170.10.4905. J Immunol. 2003. PMID: 12734333

5

Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors.

Nowak AK, Robinson BW, Lake RA. Nowak AK, et al. Cancer Res. 2003 Aug 1;63(15):4490-6. Cancer Res. 2003. PMID: 12907622

6

Mesothelin-family proteins and diagnosis of mesothelioma.

Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I. Robinson BW, et al. Lancet. 2003 Nov 15;362(9396):1612-6. doi: 10.1016/S0140-6736(03)14794-0. Lancet. 2003. PMID: 14630441

7

Current chemotherapeutic treatment of malignant pleural mesothelioma.

Nowak AK, Byrne MJ, Millward MJ, Alvarez JM, Robinson BW. Nowak AK, et al. Expert Opin Pharmacother. 2004 Dec;5(12):2441-9. doi: 10.1517/14656566.5.12.2441. Expert Opin Pharmacother. 2004. PMID: 15571462 Review.

8

Soluble mesothelin-related protein--a blood test for mesothelioma.

Robinson BW, Creaney J, Lake R, Nowak A, Musk AW, de Klerk N, Winzell P, Hellstrom KE, Hellstrom I. Robinson BW, et al. Lung Cancer. 2005 Jul;49 Suppl 1:S109-11. doi: 10.1016/j.lungcan.2005.03.020. Lung Cancer. 2005. PMID: 15950789

9

Combined chemoimmunotherapy of solid tumours: improving vaccines?

Nowak AK, Lake RA, Robinson BW. Nowak AK, et al. Adv Drug Deliv Rev. 2006 Oct 1;58(8):975-90. doi: 10.1016/j.addr.2006.04.002. Epub 2006 Aug 15. Adv Drug Deliv Rev. 2006. PMID: 17005292 Review.

10

Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.

Francis RJ, Byrne MJ, van der Schaaf AA, Boucek JA, Nowak AK, Phillips M, Price R, Patrikeos AP, Musk AW, Millward MJ. Francis RJ, et al. Among authors: nowak ak. J Nucl Med. 2007 Sep;48(9):1449-58. doi: 10.2967/jnumed.107.042333. Epub 2007 Aug 17. J Nucl Med. 2007. PMID: 17704250 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters